Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome | Annals of Clinical Microbiology and Antimicrobials | Full Text

Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome | Annals of Clinical Microbiology and Antimicrobials | Full Text

Annals of Clinical Microbiology and Antimicrobials

Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome

• Mingyu Zhang†View ORCID ID profile,
• Moira K. Differding†,
• Sara E. Benjamin-Neelon,
• Truls Østbye,
• Cathrine Hoyo and
• Noel T. MuellerEmail authorView ORCID ID profile

†Contributed equally

Annals of Clinical Microbiology and Antimicrobials201918:18

https://doi.org/10.1186/s12941-019-0318-9

©  The Author(s) 2019

• Received: 3 December 2018
• Accepted: 6 June 2019
• Published: 21 June 2019

Abstract

Background

Prenatal antibiotic exposure has been associated with an altered infant gut microbiome composition and higher risk of childhood obesity, but no studies have examined if prenatal antibiotics simultaneously alter the gut microbiome and adiposity in infants.

Method

In this prospective study (Nurture: recruitment 2013–2015 in North Carolina, United States), we examined in 454 infants the association of prenatal antibiotic exposure (by any prenatal antibiotic exposure; by trimester of pregnancy; by number of courses; by type of antibiotics) with infant age- and sex-specific weight-for-length z score (WFL-z) and skinfold thicknesses (subscapular, triceps, abdominal) at 12 months of age. In a subsample, we also examined whether prenatal antibiotic exposure was associated with alterations in the infant gut microbiome at ages 3 and 12 months.

Results

Compared to infants not exposed to prenatal antibiotics, infants who were exposed to any prenatal antibiotics had 0.21 (95% confidence interval [CI] 0.02, 0.41) higher WFL-z at 12 months, and 0.28 (95% CI 0.02, 0.55) higher WFL-z if they were exposed to antibiotics in the second trimester, after adjustment for potential confounders, birth weight, and gestational age. We also observed a dose-dependent association (P-value for trend = 0.006) with infants exposed to ≥ 3 courses having 0.41 (95% CI 0.13, 0.68) higher WFL-z at 12 months. After further adjustment for delivery method, only second-trimester antibiotic exposure remained associated with higher infant WFL-z (0.27, 95% CI 0.003, 0.54) and subscapular skinfold thickness (0.49 mm, 95% CI 0.11, 0.88) at 12 months. Infants exposed to second-trimester antibiotics versus not had differential abundance of 13 bacterial amplicon sequence variants (ASVs) at age 3 months and 17 ASVs at 12 months (false discovery rate adjusted P-value < 0.05).

Conclusions

Prenatal antibiotic exposure in the second trimester was associated with an altered infant gut microbiome composition at 3 and 12 months and with higher infant WFL-z and subscapular skinfold thickness at 12 months.

Keywords

• Gut microbiome
• Pediatric obesity
• Antibiotic
• Child health
• Prenatal exposure
• Pregnancy